Ambrosia artemisiifolia pollen is an extract from Ambrosia artemisiifolia pollen used in allergy testing.
- Primary indication
- Ambrosia artemisiifolia pollen is an allergen extract indicated as immunotherapy for the treatment of short ragweed pollen-induced allergic rhinitis, with or without conjunctivitis, confirmed by positive skin test or in vitro testing for pollen-specific IgE...Curator reviewed · 3 structured indications
- First approval
- Canada, 2017 · United States, 1941
- Also known as
- Ambrosia artemisiifolia · short ragweed pollen extract · short ragweed pollen extracts · Standardized short ragweed pollen allergenic extract
- Code names
- MK-3641 · SCH 39641
- Brand names
Resolves to
Compound
Clinical / RWD
What you can answer from here — as of September 13, 2025
Which other approved drugs treat the same conditions as Ambrosia artemisiifolia pollen, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account